UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Jun

    17

    UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)

    Read More

    Jun

    04

    Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps

    Read More

    Jun

    03

    Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis

    Read More

    Jun

    01

    UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members

    Read More